Sanctuary Advisors’s Novo Nordisk NVO Stock Holding History

Sanctuary Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Sell	220,373 -19,575	-8%	-$841K	0.05%	390
2026 Q1	$8.82M	Buy	239,948 +29,581	+14%	+$1.4M	0.05%	400
2025 Q4	$10.7M	Sell	210,367 -3,481	-2%	-$178K	0.06%	328
2025 Q3	$11.9M	Sell	213,848 -53,171	-20%	-$3.11M	0.07%	296
2025 Q2	$18.4M	Sell	267,019 -33,357	-11%	-$2.27M	0.11%	192
2025 Q1	$20.9M	Sell	300,376 -4,480	-1%	-$370K	0.15%	162
2024 Q4	$26M	Buy	304,856 +11,967	+4%	+$1.29M	0.16%	127
2024 Q3	$30.8M	Buy	292,889 +1,130	+0.4%	+$151K	0.19%	110
2024 Q2	$37M	Buy	+291,759	New	+$38.7M	0.27%	70

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sanctuary Advisors's NVO Position: Q2 2026 in Review

Sanctuary Advisors reduced its Novo Nordisk (NVO) stake by 8.2% in Q2 2026, selling an estimated $841K and leaving 220,373 shares worth $10.6M. The position accounts for 0.05% of the portfolio, ranked #390.

Sanctuary Advisors first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $37M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Sanctuary Advisors held 220,373 shares of Novo Nordisk worth $10.6M as of Q2 2026.
Sanctuary Advisors sold 19,575 Novo Nordisk shares in Q2 2026, an estimated $841K.
Novo Nordisk made up 0.05% of Sanctuary Advisors's portfolio in Q2 2026, its #390 holding.
Sanctuary Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Sanctuary Advisors's Novo Nordisk position peaked at $37M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.